Our teams are guided by performance driven results
Jean P. (“JP”) Michel Co-Founder, Managing Partner
JP Michel is a co-Founder and Managing Partner at Sethos Capital Partners. Prior to joining Sethos, Mr. Michel served as a Principal at Blue Ocean Harvest, a boutique private equity and advisory firm, where he worked closely on the firm’s frontier and emerging market infrastructure investments (port, seaports, toll roads) across the Caribbean, Central and South America, including being granted the negotiation rights to design, build and finance a US400 million rehabilitation program of an international airport in the region. Prior to, Mr. Michel successfully solely funded, built and sold a valuation risks/analytics software company called Cognit Enterprises, Inc. that delivered value at risks analytics to asset managers and investors across the United States and Europe. In addition, Mr. Michel served nearly six years working at JP Morgan investment bank serving as a Vice President to the firm. He is currently a partner at HedgeServ—a US fund administration firm with nearly US205 billion in AuA—where he leads the firm’s South American division. Mr. Michel also worked at IFS, Ltd at the Director level, an early funds administration company he lead successfully while in Dublin, Ireland and of which later was successfully acquired by US State Street Bank in 2002.
Throughout his career, Mr. Michel has advised a number of finance ministers, central bank governors and presidents across Latin America, encouraging many to adapt market based policies that would strengthen trades with country-partners and improve overall foreign direct investments in their respective countries. Mr. Michel received an Executive MBA from Columbia University Business School and a B.A. in Political Science with a concentration in Economics from the State University of New York at Stony Brook.
Mr. Michel is a peer member of Tiger 21, a private equity group with over US5 billion in investable assets. He is currently assisting (pro-bono) a large public University in the Caribbean to raise US170 million to build an advanced research lab.
Dr. Rajiv Dahiya is a graduate of the 6 year combined BA-MD program at University of Missouri – Kansas City School of Medicine. Founder of Predictive Medical Solutions, a cutting edge high complexity laboratory performing molecular as well as pharmacogenetic testing. Developed brand, strategy and financial models for design, build, own and operate (DBOO) of bringing high complexity laboratories to multiple hospital systems. Created first-in-market strategic alliance with large national telemedicine company to provide pharmacogenetic testing to self-insured employer market. Developed laboratory integration strategy for national pain medicine and spine surgery company seeking IPO. Clinical interests include unveiling the genetic codes for numerous malignant processes and using nano technologies to affect cell apoptosis and programmed cell death. Board certified in Radiation Oncology with extensive industry experience in building comprehensive multidisciplinary clinical practice platforms. He has authored numerous publications and co-author of Understanding Microinflammation: The Common Link Between Aging, Cancer and Coronary Disease. Healthcare industry consultant to Qualcomm Corp sponsored Virtual Reality (VR) technology with first ever F.A.S.T. stroke education module. Founder of Sethos Capital focusing on bringing infrastructure projects to Latin America and Caribbean.
He has been a member of Young President’s Organization (YPO) and attended the YPO-Harvard Business School (HBS) President’s Program. Selected to Top Doctors 2011-2017. He has a passion for bringing advanced cancer solutions to patients in the developing world by employing advanced clinical algorithms.